What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives

Listen Now

Topics Covered

• What are Biosimilars? Understanding Their Role in Cancer Treatment: Current and Future Perspectives, in the Context of COVID-19
• Overview and Definition of Biosimilars
• The Difference Between Biosimilars and Generic Drugs
• How Biosimilars Work and Their Use
• Examples of Biosimilars
• Implications in Managing the Cost of Cancer Treatment
• Finding Sources of Financial Assistance
• Clinical Trials: How Biosimilars’ Research Contributes to Treatment Options
• The Benefits of Biosimilars
• Current Use in the Care of People Living with Cancer
• Manufacturing and Safety Issues
• Key Questions to Ask Your Health Care Team about Biosimilars
• Current and Future Perspectives
• Questions for Our Panel of Experts

Our Panel of Experts

Richard J. Gralla, MD, FACP, FRCP Edin

Professor of Medicine, Albert Einstein College of Medicine, Jacobi Medical Center

Jeffrey Crawford, MD

George Barth Geller Professor for Research in Cancer, Department of Medicine, Duke University School of Medicine, Co-Leader , Solid Tumor Therapeutics Program, Principal Investigator of NCTN LAPS Grant, Duke Cancer Institute

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 18, 2020.